Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2008
11/19/2008CN101309925A Fused tetracyclic mglur1 antagonists as therapeutic agents
11/19/2008CN101309913A Process for the preparation of delmopinol and derivatives thereof
11/19/2008CN101307060A Process for preparing hemihydrate of levofloxacin
11/19/2008CN100434430C Indolinospirobenzoxazine compound, and synthesis method and use thereof
11/18/2008US7452993 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia
11/18/2008US7452908 Amide derivatives
11/18/2008US7452895 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer
11/18/2008US7452879 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/18/2008US7452692 Method for extracting a macrolide from biomatter
11/18/2008CA2516557C Triazole compounds useful in therapy
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2278331C 3-heterocyclyl-substituted benzoyl derivatives
11/13/2008WO2008137435A1 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/13/2008WO2008137139A1 Gamma secretase modulators
11/13/2008WO2008135291A1 New progesterone receptor modulators
11/13/2008WO2008118718A3 2-aminopyridine analogs as glucokinase activators
11/13/2008WO2008005908A3 Pyridoimidazole derivatives
11/13/2008US20080280918 phosphodiesterase enzyme inhibitor; 4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one; potent antiinflammatory agent; asthma, atopic dermatitis, psoriasis, chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease
11/13/2008US20080280892 Tricyclic nitrogen antibacterial; 1-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one; may be used with other active ingredients, diluents
11/13/2008CA2686589A1 Gamma secretase modulators
11/13/2008CA2684088A1 New progesterone receptor modulators
11/12/2008EP1989198A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
11/12/2008EP1713813B1 Polymorphic forms of a gabaa agonist
11/12/2008EP1646634B1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss
11/12/2008CN101305011A Pyridine derivatives and their use in the treatment of psychotic disorders
11/12/2008CN101305008A Tetracyclic indole derivatives as antiviral agents
11/12/2008CN101302225A Production of polyketides and other natural products
11/12/2008CN101302224A Fluorine-containing tetrahydroimidazo [1,5-b] isoxazole derivate and synthetic method thereof
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
11/06/2008WO2008132846A1 Tricyclic heteroaryl compound
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008US20080275035 Nitroimidazole Compounds
11/06/2008US20080275026 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/05/2008EP1988088A1 Thiolactones
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1987040A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
11/05/2008EP1987020A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/05/2008EP1986645A1 Glucokinase activators
11/05/2008EP1858901B1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/05/2008EP1732921B1 Thioamide derivatives as progesterone receptor modulators
11/05/2008CN101300260A Method for synthesizing spiro quaternary ammonium systems
11/05/2008CN100430404C Spiro oxazone derivative containing naphthalimide unit
11/04/2008US7446113 the prodrug forms of compounds have good absorption, pharmacokinetics, distribution and transport to the brain; 4-[8-Trifluoromethyl-6-(4-trifluoromethyl-phenyl)-imidazo[1,2-a]pyridin-3-ylethynyl]-benzenesulfonamide; nervous system disorders like psychosis, schizophrenia, Alzheimer's disease, depression
11/04/2008US7446111 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions
11/04/2008US7445916 Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
11/04/2008CA2443449C Pyrazole derivatives for treating hiv
11/04/2008CA2310458C Piperidine derivatives
10/2008
10/30/2008WO2008129280A1 Pyrazoles useful in the treatment of inflammation
10/30/2008WO2008129004A2 Heterocyclic compounds containing the morpholine nucleus their preparation and use
10/30/2008WO2008016648A3 Certain chemical entities, compositions and methods
10/30/2008US20080269302 Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
10/30/2008US20080269271 Analgesics; antidepressants; neurodegenerative diseases; antiepileptic agents; cognition activators; antitussive agents; incotinence; irritable bowel syndrome; stroke; vision defects; antiinflammatory agents; skin disorders; diarrhea; eating disorders
10/30/2008US20080269208 Antidepressant; schizophrenia; pyridine ring substituted with bicyclic nitrogen containing rings
10/30/2008US20080269195 Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine
10/30/2008US20080269192 Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds
10/30/2008US20080269061 Substituted thiene-3-ylsulphonylamino(thio)carbonyltriazolin(ethi)ones
10/30/2008US20080268010 Inhibiting growth of bacteria on implantable medical devices
10/30/2008CA2684701A1 Pyrazoles useful in the treatment of inflammation
10/30/2008CA2684679A1 Heterocyclic compounds containing the morpholine nucleus their preparation and use
10/29/2008EP1984369A2 Nitroimidazole compounds
10/29/2008EP1984357A2 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
10/29/2008EP1749011B1 Bicyclic heterocycles as hiv integrase inhibitors
10/29/2008CN101296926A Heterocyclic aspartyl protease inhibitors
10/29/2008CN100429214C Preparation of 1-aza-2-oxa-dibenzo [e,h] azulenes and their use for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/28/2008US7442795 Triazole compounds useful in therapy
10/28/2008US7442794 Stereoisomers ; reacting with Lewis acid; purification
10/28/2008US7442707 provides CCI-779 polymorph Form II. This invention also provides processes for preparing CCI-779 polymorph Form II and pharmaceutical compositions including CCI-779 polymorph Form II.
10/28/2008US7442672 Applying to plants
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/23/2008WO2008127361A2 Synthesis of enone intermediate
10/23/2008WO2008126943A2 Method for manufacturing neuraminic acid derivatives
10/23/2008WO2008126384A1 Method for producing quinolone carboxylic acid derivative
10/23/2008WO2008125658A1 4,5,11,11a-tetrahydro-1h,6h-oxazolo[3',4':1,6]pyrido[3,4-b]indol-3-one derivatives and therapeutic use thereof
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008WO2008035315A9 Inhibitors of phosphodiesterase type-iv
10/23/2008WO2007046022A3 Inhibitors of phosphodiesterase type-iv
10/23/2008US20080262221 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES
10/23/2008US20080262220 Polymorphic forms alpha, beta and gamma of rifaximin
10/23/2008US20080262029 Acid and Base Salt Forms of Gaboxadol
10/23/2008US20080261965 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
10/23/2008US20080261963 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer
10/23/2008US20080261951 Condensed azepines as vasopressin agonists
10/23/2008US20080260754 Prevent transplant rejection; autoimmune diseases
10/23/2008CA2683065A1 Method for manufacturing neuraminic acid derivatives
10/23/2008CA2682932A1 A method for the preparation of an enantiomerically pure benzazepine
10/23/2008CA2679852A1 Method for producing quinolone carboxylic acid derivative
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008EP1697359B1 Muscarinic agonists as therapeutic compounds
10/22/2008CN101289455A Anti-influenza virus precursor drug and uses thereof
10/21/2008US7439355 Process for the production of oxabispidines
10/21/2008US7439354 Process for preparing amide acetals
10/21/2008US7439252 Ascomycin crystalline forms and preparation thereof
10/21/2008CA2296012C Epothilone derivatives
10/21/2008CA2282345C Pharmaceutical composition
10/21/2008CA2210913C Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
10/16/2008US20080255210 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 220